thrombolytic,英語單詞,主要用作形容詞、名詞,作形容詞時譯為“溶解血栓的”,作名詞時譯為“溶解血栓劑”。
基本介紹
- 外文名:thrombolytic
- 詞性:形容詞、名詞
- 英式發音:[θrɑːmboʊˈlɪtɪk]
- 釋義:溶解血栓的|溶解血栓劑

thrombolytic,英語單詞,主要用作形容詞、名詞,作形容詞時譯為“溶解血栓的”,作名詞時譯為“溶解血栓劑”。
Classification: Thrombolytic enzyme Action/Kinetics: Prepared by acylating human plasma derived from lys-plasminogen and purified streptokinase derived from group C beta-hemolytic streptococci. When prepared, anistreplase is an inactive derivative of a fibrinolytic enzyme although the compound can still ...
溶血栓藥 溶血栓藥(thrombolytics)是2014年公布的藥學名詞。定義 可使血管中血栓纖維蛋白凝塊溶解、恢復血供的藥物。如阿替普酶、尿激酶、鏈激酶、瑞替普酶、拉諾替普酶等。出處 《藥學名詞》第二版。
溶栓療法 溶栓療法(thrombolytic therapy)是2020年公布的手外科學名詞。定義 採用溶栓藥物溶解已形成血栓的治療方法。出處 《手外科學名詞》第一版。
TIMI flow grade是用來評估各種溶血物質(thrombolytic agents)的功效。TIMI分四個等級 TIMI 0 級:無再灌注或閉塞遠端無血流,梗死相關冠狀動脈完全閉塞,遠端 無造影劑通過;TIMI 1級:少量造影劑通過血管阻塞處,但遠端動脈不顯影;TIMI 2級:梗死 相關冠狀動脈完全顯影,但與正常血管相比血流較緩慢;TIMI 3級:...
纖維蛋白溶解藥(fibrinolytic drugs)激活纖溶酶而促進纖溶,也稱溶栓藥(thrombolytic drugs),用於治療急性血栓栓塞性疾病。第一代的溶栓藥鏈激酶(SK)和尿激酶(UK)至今仍然是國內外使用最廣泛的品種,隨著尿激酶原(Pro-UK)等新一代溶栓藥的問世,這類藥物正在臨床逐漸推廣套用。血栓與水蛭素 水蛭素是一類很有...
r-PA)和尿激酶原(pro-UK)目前正在進行臨床研究,瑞替普酶(Reteplase)為一種重組纖溶酶原激活劑是野生型阿替普酶(t-PA)非糖基化缺陷體,有兩個分子結構點不同於阿替普酶(t-PA),由於有分子缺失區域而導致半衰期延長,在最近INJECT究中(International Joint Efficiency Comparision of Thrombolytic Trial) 瑞替...
92 Contemporary Thrombolytic Therapy in Acute Myocardial Infarction Yves Janin,MD·Micbael L.Hess,MD,FACC 93 Interventional Therapies for Cardiogenic Shock Yves Janin,MD·George Vetrovec,MD,FACC Michael L.Hess,MD,FACC 94 Congestive Heart Failure in Infants and Children Bradley P.Fubrman,MD·Lynn J...
5 Thrombolytic Intervention 6 Hypolipidemic intervention and Plaque Stabilization SECTION II CORONARY AND PERIPHERAL INTERVENTION: KEY APPLICATIONS Coronary and Peripheral Angioplasty: Historical Perspective Elective Coronary Angioplasty: Technique and Complications Abrupt Vessel Closure Complex...
Streptokinase and urokinase are important in thrombolytics, and asparaginase is used as a cytostatic agent in the treatment of leukemia.鏈激酶和尿激酶溶栓是重要的,是天冬醯胺酶在治療白血病細胞生長劑。Conclusion Thrombolytic therapy of high dose urokinase impact for central retinal artery occlusion is ...
Streptokinase and urokinase are important in thrombolytics, and asparaginase is used as a cytostatic agent in the treatment of leukemia.鏈激酶和尿激酶溶栓是重要的,是天冬醯胺酶在治療白血病細胞生長劑。The availability of new cytostatic agents and other drugs may improve the resectability of liver ...
12.7 抗凝血藥和溶血栓藥物(antico agulantand thrombolytic agents)12.7.1 抗凝血藥(anticoagulant)12.7.2 抗血小板聚集藥(drugs againt platelet aggregation)12.7.3 溶血栓藥(drugs for thrombolysis)12.8 遺傳性血管神經性水腫用藥(drugs for hereditary angioneurotic edema)第十三章 激素及...
報告題目: Outcomes of Intravenous Thrombolytic Therapy for Acute Ischemic Stroke with Integrated Acute Sroke Referral Network: Initial Experience of Community-based Hospital in a Developing Country 報告人:Sombat Muengtaweepongsa博士,泰國國立法政大學醫學部門主席 論壇8: 公共心臟健康,護理,傳統中醫及預防心臟...
92 Contemporary Thrombolytic Therapy in Acute Myocardial Infarction Yves Janin,MD·Michael L.Hess,MD,FACC 93 Interventional Therapies for Cardiogenic Shock Yves Janin,MD·George Vetrovec,MD,FACC Michael L.Hess,MD,FACC 94 Congestive Heart Failure in Infants and Children Bradley P.Fuhrman,MD·Lynn J....
Anti-coagulation and thrombolytic therapy for MVT is feasible when the initial diagnosis is certain and bowel infarction has not let to transmural necrosis and bowel perforation.急性MVT在腸缺血尚未導致透壁性腸壞死、腸穿孔時,抗凝溶栓治療可行,如有急性腹膜炎時中轉手術。
Thrombolytic therapy and anti-coagulation could effective improve the prognosis of PE patients. 溶栓治療和抗凝治療可有效改善患者預後。In addition, coagulated tissue ACTS as a barrier to further penetration of acid (coagulation necrosis). 除此之外,凝固的組織也可作為屏障防止酸的進一步滲透(凝固性壞死)。
[8] Efficacy of te lemedicine for thrombolytic therapy in acute ischemic stroke. Journal of Telemedicine & Telecare, 2015, 21(3):123-130,SCI(影響因子6.184),第一作者 [9] Effectiveness of Telemedicine for Controlling Asthma Symptoms, Telemedicine and e-Health, 2015, SCI(影響因子3.536), ...
The decision to institute treatment should be left to the consulting ophthalmologist and may include surgical decompression, fibrinolytic or thrombolytic agents, systemic steroids, and hemodilution.是否治療的決定應由參與會診的眼科醫生作出,具體措施包括手術減壓,纖溶或溶栓藥物,全身甾體激素治療以及血液稀釋療法...
1. Percutaneous Transluminal Coronary Angioplasty and Thrombolytic Therapy in Myocardial Infarction 2. Coronary Artery Bypass Graft 3. Cardiogenic Shock and Anterior Wall Myocardial Infarction 4. Non-Q-Wave Myocardial Infarction 5. Heart Failure 6. Carotid Endarterectomy 7. Abdominal ...
18. Laboratory Control of Anticoagulant, Thrombolytic and Antiplatelet Therapy 19. Blood Cell Antigens and Antibodies: Erythrocytes, Platelets and Granulocytes 20. Laboratory Aspects of Blood Transfusion 21. Molecular and Cytogenetic Analysis 22. Miscellaneous Tests 23. Approach to the Diagnosis and ...
l Hui J, Dai YJ, Bian YY, Li H, Cui XJ, You S,Hu FQ*. (2012) Construction of novel chimeric proteins possessing the bifunctions of anti-tumor and thrombolytic.J Microbiol Biotechnol 22(7): 894–901.(SCI收錄)l Hui J, Cao Y, Zhang J, Li H, Yang HM, Yu JP,Hu FQ* (2008)...
